Coronavirus Infection (COVID-19) and Radical Surgery in Patients With Early-stage Lung Cancer
NCT05684549 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2024-06-27
Summary
The goal of this observational study is to learn about the effects of coronavirus infection in patients with early-stage lung cancer. The main question it aims to answer is whether the interval of surgery and COVID-19 infection will affect the surgery and prognosis of the patients.
Conditions
- Surgery
- Corona Virus Infection
Interventions
- OTHER
-
No intervention
Observational study, no intervention
Sponsors & Collaborators
-
Ruijin Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-11
- Primary Completion
- 2024-04-30
- Completion
- 2024-12-31
Countries
- China
Study Locations
More Related Trials
-
Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform
NCT06483295 ·Status: RECRUITING ·Phase: NA
-
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
NCT06534489 ·Status: RECRUITING
-
Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer
NCT02941003 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients
NCT03429673 ·Status: COMPLETED
-
Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014)
NCT05794698 ·Status: COMPLETED
-
A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy
NCT07119190 ·Status: NOT_YET_RECRUITING
-
Significance of MRD After Surgery in Driver Gene-positive and Driver Gene-negative Stage IB-IIA NSCLC
NCT05441566 ·Status: ENROLLING_BY_INVITATION
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors
NCT05834413 ·Status: RECRUITING ·Phase: NA
-
Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients
NCT05009030 ·Status: COMPLETED
-
Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy
NCT07257471 ·Status: RECRUITING
-
cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation Operation
NCT04413656 ·Status: UNKNOWN ·Phase: NA
-
Microwave Ablation in the Treatment of Stage I Non Small Cell Lung Cancer
NCT02896166 ·Status: UNKNOWN ·Phase: PHASE3
-
Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer
NCT06503744 ·Status: RECRUITING ·Phase: NA
-
Circulating Immune Markers for Prognostic Evaluation in Postoperative Lung Cancer Patients
NCT07242482 ·Status: NOT_YET_RECRUITING
-
Immuno-effect of Tα1 for Stage I NSCLC
NCT06598839 ·Status: RECRUITING ·Phase: NA
-
Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy
NCT07256002 ·Status: ACTIVE_NOT_RECRUITING
-
Right Side of Heart Function After Lung Surgery
NCT01892800 ·Status: UNKNOWN
-
Efficacy and Safety of Cryoablation with Robotic Bronchoscopy System in Patients with Lung Cancer
NCT06832956 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of Confinement and Preventive Measures in Period of SARS-COV2 Infection on Clinical Features, Diagnostic and Therapeutic Management and Prognosis of Patients With Lung Cancer
NCT04366219 ·Status: UNKNOWN
-
Postoperative Chronic Operation-related Symptoms After Minimally Invasive Lung Surgery
NCT06016881 ·Status: UNKNOWN
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED
-
Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
NCT02288026 ·Status: UNKNOWN
-
Construction of a Prognostic and Prediction Model for Perioperative Immunotherapy in NSCLC: a Multi - Omics Perspective
NCT06856798 ·Status: NOT_YET_RECRUITING
-
Interventional Ablation for Early-stage Lung Cancer
NCT07005999 ·Status: ACTIVE_NOT_RECRUITING